Patents by Inventor Justine S. McPARTLAN

Justine S. McPARTLAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TAIL-CONJUGATED RNAS
    Publication number: 20230346980
    Abstract: Tail-tail RNA conjugates translatable by eukaryotic ribosomes, and pharmaceutically acceptable compositions including the same are provided. Methods for preparing such molecules, using them for treating and preventing diseases are described. In addition, processes for producing desired polypeptides using the molecules are also described.
    Type: Application
    Filed: April 27, 2023
    Publication date: November 2, 2023
    Applicant: Tiba Biotech
    Inventors: Jasdave S CHAHAL, Justine S McPARTLAN
  • ARTIFICIAL ALPHAVIRUS-DERIVED RNA REPLICON EXPRESSION SYSTEMS
    Publication number: 20230295241
    Abstract: Synthetic alphavirus-derived replicon expression systems comprising nucleic acid sequences encoding at least one modified nonstructural protein, and synthetic nucleic acid sequences encoding at least one heterologous protein are described. Methods of producing at least one heterologous protein in a cell, or of inducing an immune response in a subject by administering and/or expressing the synthetic alphavirus-derived replicon expression systems are provided.
    Type: Application
    Filed: February 10, 2023
    Publication date: September 21, 2023
    Applicant: TIBA BIOTECH
    Inventors: Jasdave S CHAHAL, Justine S. McPARTLAN
  • Artificial alphavirus-derived RNA replicon expression systems
    Patent number: 11613561
    Abstract: Synthetic alphavirus-derived replicon expression systems comprising nucleic acid sequences encoding at least one modified nonstructural protein, and synthetic nucleic acid sequences encoding at least one heterologous protein are described. Methods of producing at least one heterologous protein in a cell, or of inducing an immune response in a subject by administering and/or expressing the synthetic alphavirus-derived replicon expression systems are provided.
    Type: Grant
    Filed: March 18, 2022
    Date of Patent: March 28, 2023
    Assignee: TIBA BIOTECH, LLC
    Inventors: Jasdave S Chahal, Justine S McPartlan
  • ARTIFICIAL ALPHAVIRUS-DERIVED RNA REPLICON EXPRESSION SYSTEMS
    Publication number: 20220298210
    Abstract: Synthetic alphavirus-derived replicon expression systems comprising nucleic acid sequences encoding at least one modified nonstructural protein, and synthetic nucleic acid sequences encoding at least one heterologous protein are described. Methods of producing at least one heterologous protein in a cell, or of inducing an immune response in a subject by administering and/or expressing the synthetic alphavirus-derived replicon expression systems are provided.
    Type: Application
    Filed: March 18, 2022
    Publication date: September 22, 2022
    Applicant: TIBA BIOTECH
    Inventors: Jasdave S. CHAHAL, Justine S. McPARTLAN